• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Oppenheimer Concludes 20th Annual Professionals Alliance Group (PAG) Conference

    11/13/24 12:30:00 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance
    Get the next $OPY alert in real time by email

    Event Gathered CPAs and Other Trusted Industry Professionals with Select Group of Oppenheimer Advisors, Investment Managers and Senior Leadership to Collaborate on Strategies to Deliver Enhanced Client Service

    PAG Referral and Partnership Program Model Enables Accounting Firms and Others to Access Oppenheimer's Wealth Management, Capital Markets, and Investment Banking Capabilities

    NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading wealth management and investment banking firm, and subsidiary of Oppenheimer Holdings (NYSE:OPY) — today announced the completion of its 20th annual Professionals Alliance Group (PAG) Conference.

    The event, held November 12-13 at the firm's New York headquarters, brought together a select group of Oppenheimer's financial advisors, investment managers and senior leadership with Certified Public Accounting firms and other trusted industry partners to discuss macro trends and strategies to best serve clients.

    "This year's Professionals Alliance Group's annual conference came at a critical time for the industry, and was held against the backdrop of a complex macroeconomic environment, potential shifts resulting from the incoming administration and fast-evolving client expectations," said Bryan McKigney, President of Oppenheimer Asset Management. "We were proud to bring together leaders and forward-thinking experts in their respective fields to explore effective solutions and growth strategies."

    Oppenheimer pioneered the Professionals Alliance Group in 1997. It has since grown into one of the financial industry's premier referral and partnership programs.

    The unique model allows CPAs, lawyers, family offices and other professional services providers to integrate the full scope of Oppenheimer's wealth management, capital markets and investment banking capabilities, resulting in expanded offerings and a more comprehensive approach to serving clients.  

    Notably, the 20th annual PAG Conference featured sessions on tax-efficient strategies that highlighted The Power of Oppenheimer Thinking, such as tax-exempt fixed income, 1031 exchanges, tax-managed direct indexing and exchange funds.

    "Since its inception, the Professionals Alliance Group has set the industry standard for collaboration and innovation," said Daniel Mullen, Executive Director of PAG. "Oppenheimer's wealth management capabilities empower accounting firms and other trusted advisory practices to deliver more robust client-centered solutions. This event underscored our dedication to advancing these partnerships and exploring new ways to bring value to advisors and clients."

    Oppenheimer & Co. Inc.

    Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions. 

    Media Contact:

    Joseph Kuo / Michael Dugan 

    Haven Tower Group LLC 

    424 317 4851 or 424 317 4852

    [email protected] or [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/oppenheimer-concludes-20th-annual-professionals-alliance-group-pag-conference-302304468.html

    SOURCE Oppenheimer & Co. Inc.

    Get the next $OPY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OPY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OPY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Lowenthal Robert S bought $3,056 worth of Class A non-voting common stock (46 units at $66.88) (SEC Form 5)

    5 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    2/9/26 4:11:27 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Lowenthal Albert G bought $11,930 worth of Class A non-voting common stock (178 units at $66.88) (SEC Form 5)

    5 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    2/9/26 4:11:08 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Director Lowenthal Robert S acquired 35,505 units of Class A non-voting common stock, increasing direct ownership by 38% to 129,608 units (SEC Form 4)

    4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    1/29/26 4:48:48 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings

    NEW YORK, Jan. 30, 2026 /CNW/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%.  For the year ended December 31, 2025, the Company reported net income of $148.4 million or $14.13 basic earnings per share compared with net income of $71.6 million or $6.91 basic earnings per share for the year en

    1/30/26 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    OPPENHEIMER HOLDINGS INC. DECLARES SPECIAL DIVIDEND

    NEW YORK, Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million. The special dividend will be funded through OPY's existing cash management activities. Robert S. Lowenthal, President and Chief Executive Officer, commented: "We are pleased to recognize the year's operating results and our improved financial position through the announcement of a special dividend of $1

    12/12/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.

    The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areas NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City. Biliouris comes to Oppenheimer from BMO Capital Markets, where he was a Director, mainly covering the genetic medicines space. Before BMO, he was a VP in Biotech Research at Morgan Stanley and worked in drug development and produc

    12/8/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    SEC Filings

    View All

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    2/2/26 10:01:01 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    1/30/26 8:13:15 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    12/12/25 8:13:58 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oppenheimer Holdings, Inc. (Amendment)

    SC 13G/A - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)

    9/23/21 3:31:42 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G filed by Oppenheimer Holdings, Inc.

    SC 13G - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)

    6/25/21 2:44:05 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Leadership Updates

    Live Leadership Updates

    View All

    Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.

    The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areas NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City. Biliouris comes to Oppenheimer from BMO Capital Markets, where he was a Director, mainly covering the genetic medicines space. Before BMO, he was a VP in Biotech Research at Morgan Stanley and worked in drug development and produc

    12/8/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer & Co. Inc. Appoints Keith Peterson As Head of Cash Equity Sales and Trading

    Veteran equity markets leader joins to oversee trading operations and advance cross-platform growth initiatives NEW YORK, Nov. 17, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings (NYSE:OPY) — today announced that Keith Peterson has joined the firm as Managing Director and Head of Cash Equity Sales and Trading. He will report to John Hellier, Senior Managing Director and Head of Equities. In this role, Peterson will oversee all supervisory and operational activities for Oppenheimer's equity sales and trading team, working closely with other leaders in the Equities division and across the firm to ensure continued

    11/17/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Announces the Appointment of Public Finance Banker Guy T. Logan as Managing Director, Head of Infrastructure & Mid-Atlantic Region

    Addition of respected industry veteran highlights the rapid expansion of the firm's Public Finance team NEW YORK, Oct. 29, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced it has hired Guy T. Logan to serve as Managing Director, Head of Infrastructure & Mid-Atlantic Region within the firm's Public Finance Investment Banking Division. He will report to Beth Coolidge, Managing Director and Head of Public Finance. Logan joins Oppenheimer with more than 30 years of municipal finance experience. Over the course of his career, he has served as senior or lead banker on more th

    10/29/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Financials

    Live finance-specific insights

    View All

    Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings

    NEW YORK, Jan. 30, 2026 /CNW/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%.  For the year ended December 31, 2025, the Company reported net income of $148.4 million or $14.13 basic earnings per share compared with net income of $71.6 million or $6.91 basic earnings per share for the year en

    1/30/26 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    OPPENHEIMER HOLDINGS INC. DECLARES SPECIAL DIVIDEND

    NEW YORK, Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million. The special dividend will be funded through OPY's existing cash management activities. Robert S. Lowenthal, President and Chief Executive Officer, commented: "We are pleased to recognize the year's operating results and our improved financial position through the announcement of a special dividend of $1

    12/12/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. Reports Third Quarter 2025 Earnings

    NEW YORK, Oct. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the third quarter of 2025, compared with net income of $24.5 million or $2.38 basic earnings per share for the third quarter of 2024. Third quarter 2025 results were significantly impacted by higher pre-tax compensation expenses for liability-based awards totaling $13.5 million or $0.95 basic earnings per share (after tax), attributable to an increase in the OPY Class A share price (increased $8.30 per share during the quarter). Revenue for the third quarter of 2025 was $424.4 million, an increase of 13.7%, comp

    10/31/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance